Follow-up of the Marketing Authorisation dossiers for medicinal products

The steering committee comprising a representative of the Minister of Social Affairs and Public Health, representatives of the FAMHP and the pharmaceutical industry has established an action plan to eliminate the backlog, prevent a new backlog and respect the legal time limit for the management of the MA dossiers for medicines for human use.

Circular 542  (French version) and its annexes (annexe 1, annexe 2, annexe 3,annexe 4, annexe 5, annexe 6, annexe 7) show and explain the action plan. It consists of 8 major actions of which 4 come into force on 01/07/2009.

Questions or comments concerning this action plan can be sent by e-mail: actionplan@fagg-afmps.be

 

 

 

 

 

 

 

 

 

 

 

 

Last updated on 28/01/2013